Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Galapagos NV (GLPG)

$167.50 4.68 (2.72%)

17:30 EDT GLPG Stock Quote Delayed 15 Minutes

Volume:

Previous Close $167.50

Market Cap 8.60B

PE Ratio -

EPS -

Volume (Avg. Vol.) 163,914

Day's Range 166.09 - 169.87

52-Week Range 85.00 - 191.63

Dividend & Yield N/A (N/A)

GLPG Stock Predictions, Articles, and Galapagos NV News

From InvestorPlace
From the Web

5 Biotech Stocks to Buy for a Strong Growth Prognosis

By Aaron Levitt, InvestorPlace Contributor Jul 23, 2019

The long term is rosy for these five biotech stocks. They have the pipelines, partners and marketed drugs to provide years of growth for investors.

Nasdaq Today: Bitcoin & Libra; What’s Broadcom Doing?

By Bret Kenwell, InvestorPlace Contributor Jul 15, 2019

It was quiet for the Nasdaq today, but bitcoin, Facebook's Libra and the Broadcom-Symantec deal were in focus.

Galapagos Deal: GLPG Stock Rockets Higher on Gilead Stake

By William White, InvestorPlace Writer Jul 15, 2019

A Galapagos deal with Gilead that includes a collaboration and an investment in the company has GLPG stock heading higher on Monday.

5 Clinical-Stage Biotech Stocks to Buy

By Aaron Levitt, InvestorPlace Contributor Feb 25, 2019

There are plenty of potential in clinical-stage biotech stocks. Here are five with some wonderful catalysts.

5 Beaten-Down Biotech Stocks to Pick Up from the Wreckage

By Aaron Levitt, InvestorPlace Contributor Oct 17, 2018

After the market's rout, biotech stocks offer a huge value right now. Here are 5 that offer the best opportunities for investors.

Biggest Movers in Manufacturing Stocks Now – BSPM RTTR SCL CCXI

By Portfolio Grader Oct 18, 2016

The following stocks were the biggest movers and shakers in the Manufacturing sector today.

Compare Brokers

Gilead Sciences, Inc. Is More Than an HCV Play (GILD)

By James Brumley, InvestorPlace Feature Writer Oct 12, 2016

Gilead Sciences (GILD) stock is a bargain at these prices. Traders just have yet to see the glass as half full.

Best & Worst Performing Mid Cap Stocks for August 19, 2019

From StockNews.com Aug 19, 2019

SINA – SINA leads the way today as the best performing mid cap stock, closing up 15.41%.

Analysts Are Bullish on These Healthcare Stocks: Cumberland Pharmaceuticals Inc (CPIX), Seres Therapeutics (MCRB)

From Analyst Ratings Aug 19, 2019

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cumberland Pharmaceuticals Inc (CPIX – Research Report), Seres Therapeutics (MCRB – Research Report) and Galapagos NV (GLPG – Research Report) with bullish sentiments. Cumberland Pharmaceuticals Inc (CPIX) Cumberland Pharmaceuticals Inc received a Buy rating and a $12.25

FDA OKs AbbVie's Rinvoq rheumatoid arthritis; shares up 2%

From Seeking Alpha Aug 16, 2019

The FDA approves AbbVie (ABBV +2.1%) JAK inhibitor RINVOQ (upadacitinib) for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have failed to respond ade

Gilead's (GILD) Filgotinib MAA for RA Accepted in Europe

From Zacks Investment Research Aug 16, 2019

The EMA accepts Gilead (GILD) and Galapagos' MAA for filgotinib as a treatment for rheumatoid arthritis.

Benzinga's Top Upgrades, Downgrades For July 31, 2019

From Benzinga Jul 31, 2019

Upgrades According to Argus, the prior rating for American Campus Communities Inc (NYSE: ACC) was changed from Hold to Buy. American Campus earned $0.56 in the second quarter,...

Gilead Sciences Beats Second-Quarter Earnings Expectations

From Barron's Jul 30, 2019

The biotech company, which slightly raised its projected sales for the full fiscal year, attributed its earnings growth to sales of its HIV drugs.

Navellier Ratings

Powered by Portfolio Grader

Total Grade

B

Buy

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!